Education
About Us
Working with TipRanks
Follow Us
Myomo Inc (MYO)
:MYO
MYO Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.92 - $7.17
Previous CloseN/A
Volume192.17K
Average Volume (3M)1.01M
Market Cap
$36.86M
Enterprise Value$86.77M
Total Cash (Recent Filing)$15.48M
Total Debt (Recent Filing)$12.43M
Price to Earnings (P/E)―
Beta1.97
Next Earnings
Nov 05, 2025EPS Estimate
-0.09Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.11
Shares Outstanding37,801,070
10 Day Avg. Volume2,188,737
30 Day Avg. Volume1,012,390
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap2.35
Enterprise Value/Revenue2.13
Enterprise Value/Gross Profit3.07
Enterprise Value/Ebitda-10.39
Forecast
1Y Price Target
$5.60Price Target Upside391.23% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering6
Bulls Say, Bears Say
Bulls Say
Financial PerformanceRevenue was ahead of expectations, with management taking action to improve lead quality and conversion metrics, positioning the company well for future growth.
Market PositionThe MyoPro product is well-positioned to address a largely untapped market for individuals with upper-arm paralysis.
Operational EfficiencyThe company is actively expanding its manufacturing capabilities and has initiatives in place to lower costs and improve efficiency.
Bears Say
Gross MarginThe company's gross margin dropped to 63% from 67% due to higher material and overhead spending and lower volume.
Patient PipelineThe number of patients added to Myomo's pipeline was significantly lower than expected, impacting the company’s revenues.
Revenue GuidanceLower-than-expected 3Q25 revenue guidance and reduced full-year 2025 guidance highlight challenges with lead quality and slower authorizations.
Myomo News
MYO FAQ
What was Myomo Inc’s price range in the past 12 months?
Myomo Inc lowest stock price was $0.92 and its highest was $7.17 in the past 12 months.
What is Myomo Inc’s market cap?
Myomo Inc’s market cap is $36.86M.
When is Myomo Inc’s upcoming earnings report date?
Myomo Inc’s upcoming earnings report date is Nov 05, 2025 which is in 77 days.
How were Myomo Inc’s earnings last quarter?
Myomo Inc released its earnings results on Aug 11, 2025. The company reported -$0.11 earnings per share for the quarter, missing the consensus estimate of -$0.106 by -$0.004.
Is Myomo Inc overvalued?
According to Wall Street analysts Myomo Inc’s price is currently Undervalued.
Does Myomo Inc pay dividends?
Myomo Inc does not currently pay dividends.
What is Myomo Inc’s EPS estimate?
Myomo Inc’s EPS estimate is -0.09.
How many shares outstanding does Myomo Inc have?
Myomo Inc has 37,801,070 shares outstanding.
What happened to Myomo Inc’s price movement after its last earnings report?
Myomo Inc reported an EPS of -$0.11 in its last earnings report, missing expectations of -$0.106. Following the earnings report the stock price went down -38.636%.
Which hedge fund is a major shareholder of Myomo Inc?
Currently, no hedge funds are holding shares in MYO
Myomo Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$5.60 (391.23% Upside)
$5.60 (391.23% Upside)
Blogger Sentiment
Neutral
MYO Sentiment 50%
Sector Average 70%
Sector Average 70%
Insider Transactions
Bought Shares
Worth $102.0K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 1.0%
Last 30 Days ▲ 8.4%
Last 30 Days ▲ 8.4%
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-69.81%
12-Months-Change
Fundamentals
Return on Equity
-68.32%
Trailing 12-Months
Asset Growth
138.86%
Trailing 12-Months
Company Description
Myomo Inc
Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. Its products are designed to help improve function in adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products to orthotics and prosthetics providers, the Veterans Health Administration, and rehabilitation hospitals, as well as through distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Boston, Massachusetts.
MYO Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlighted strong revenue growth and international expansion, particularly in Germany, and a record number of pipeline additions. However, the company faced challenges with lead quality and conversion, increased operating expenses, and a decrease in Medicare Advantage revenue. Myomo is making strategic adjustments to address these issues, including cost-cutting measures and shifts in advertising strategy.View all MYO earnings summariesMYO Stock 12 Month Forecast
Average Price Target
$5.60
▲(391.23% Upside)
Technical Analysis
Ownership Overview
16.80% Insiders
5.41% Mutual Funds
25.77% Other Institutional Investors
45.29% Public Companies and
Individual Investors